Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MMP9 | P14780 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19113262 | 0.85 | ALDH1A1 (0.33) | NLRP3USP2TSHRKDM4EALDH1A1 | |
| SCHEMBL28923200 | 0.81 | — | — | |
| SCHEMBL10032795 | 0.77 | PTGS1 (0.36) | LMNA | |
| SCHEMBL7141142 | 0.72 | — | — | |
| SCHEMBL8550113 | 0.71 | NLRP3 (0.39) | NLRP3USP2TSHRKDM4EALDH1A1 | |
| SCHEMBL1223591 | 0.69 | — | — | |
| SCHEMBL171773 | 0.69 | — | — | |
| SCHEMBL219854 | 0.67 | — | — | |
| SCHEMBL164302 | 0.67 | USP2 (0.60) | NLRP3USP2TSHRKDM4EALDH1A1 | |
| SCHEMBL17491112 | 0.67 | USP2 (0.39) | NLRP3USP2TSHRKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170301953-A1 | FUNCTIONALIZED SILANES AND ELECTROLYTE COMPOSITIONS AND ELECTROCHEMICAL DEVICES CONTAINING THEM | ORBIA FLUOR & ENERGY MATERIALS USA, INC. | 2017-10-19 | — | — | US | disclosed |
| US-20170301953-A1 | FUNCTIONALIZED SILANES AND ELECTROLYTE COMPOSITIONS AND ELECTROCHEMICAL DEVICES CONTAINING THEM | ORBIA FLUOR & ENERGY MATERIALS USA, INC. | 2017-10-19 | — | — | US | disclosed |
| WO-2016054621-A1 | FUNCTIONALIZED SILANES AND ELECTROLYTE COMPOSITIONS AND ELECTROCHEMICAL DEVICES CONTAINING THEM | SILATRONIX, INC. (US) | 2016-04-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170301953-A1 | FUNCTIONALIZED SILANES AND ELECTROLYTE COMPOSITIONS AND ELECTROCHEMICAL DEVICES CONTAINING THEM | ZYX, HCN4, HCN3 | NLRP3 3480/4885USP2 4752/4885TSHR 1712/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.